Nanobiosym
We're hiring — explore open roles below and apply in a few clicks.
Location
Headquarters: Cambridge, Massachusetts, United States, North America
Region: Massachusetts
Country: US
Continent: North America
About
Nanobiosym is a biotechnology company focused on advancing healthcare through innovative physics-based nanobiotechnology and biomedicine. It develops and commercializes rapid, portable diagnostic technologies, including the Gene-RADAR platform and Nanobiosym Diagnostics (NBSDx), to empower global health with decentralized, point-of-care capabilities. Headquartered in Cambridge, Massachusetts, the company emphasizes global partnerships and initiatives to bring cutting-edge health technologies to diverse populations.
Nanobiosym develops portable diagnostic technologies using physics-based nanobiotechnology to enable rapid, point-of-care detection of pathogens. Its primary product, Gene-RADAR, allows for the identification of genetic fingerprints from diseases such as COVID-19. The company targets global health systems, governments, and NGOs to provide decentralized healthcare solutions.
Nanobiosym, Inc.
2004
for_profit
active
Industries
Primary Industry: Manufacturing
Categories
Funding & Financials
Early Stage
1m-10m
private
Founders
Dr. Anita Goel, MD, PhD
Leadership
Technology Stack
Products
Gene-RADAR: A portable nanotechnology platform that can rapidly and accurately detect genetic fingerprints from any biological organism.
Nanobiosym Precision Testing Services: Services that provide customized R&D and testing for medical diagnostics or treatment selection purposes.
Contract R&D and Medical Research Services: Research and development services tailored to medical diagnostics and treatment selection.
Scientific/Deep Tech Consulting and Due Diligence Services: Consulting services for data management, data processing, and data compilation across various projects.
True Point of Care Services: Services designed to deliver healthcare diagnostics and monitoring at the point of care.
NANO-PCR based Services: Contract research and consulting services using Nano-PCR systems for health monitoring, environmental monitoring, and digital diagnostics.